RxDoctor Payments Data

Cathy Greenlee

Family · Lebanon, MONPI 1427537307

Payments from drug & device makers

$270in general payments, 2019–2025

Across 15 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$68
  • Merck$47
  • Lilly USA, LLC$39
  • Otsuka America Pharmaceutical, Inc.$33
  • Abbott$21
  • AbbVie$17
  • plus $45 from 3 others

What the payments were for

  • Food & beverage$270100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$270 in reported general payments places this provider in the 40th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$20,163
Medicare patients
112
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$26,897
RybelsusSemaglutide17$25,318
EliquisApixaban21$22,454
JardianceEmpagliflozin21$18,140
JanuviaSitagliptin Phosphate20$13,554
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$13,200
FarxigaDapagliflozin Propanediol14$9,781
SymbicortBudesonide/Formoterol Fumarate14$5,866
XareltoRivaroxaban17$5,586
Fluticasone-SalmeterolFluticasone Propion/Salmeterol49$5,339
Bupropion XlBupropion Hcl27$3,896
Albuterol Sulfate HfaAlbuterol Sulfate155$3,878
Lubiprostone16$3,417
Gabapentin178$3,408
Lantus SolostarInsulin Glargine,hum.Rec.Anlog28$3,202

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$68$52,21539 claims
AstraZenecaFarxiga, Symbicort$13$15,64728 claims
MerckJanuvia$47$13,55420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,812 family providers in Missouri.

Other family in Lebanon

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →